Spain's Grifols reports fivefold increase in 2012 profit

MADRID Thu Feb 28, 2013 2:39am EST

Related Topics

MADRID Feb 28 (Reuters) - Spanish pharmaceutical company Grifols reported a more than fivefold rise in full-year profit for 2012 to 257 million euros ($336.90 million), buoyed by its acquisition of U.S. firm Talecris last June and its wide geographic presence outside its depressed home market.

Barcelona-based Grifols said sales grew 46 percent year-on-year to reach 2.6 billion euros, in line with analyst expectations. ($1 = 0.7628 euros) (Reporting By Sonya Dowsett; Editing by Clare Kane)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.